Perrigo Company PLC (NYSE:PRGO)
| 45.62 Delayed Data As of Oct 23 |  +0.14 / +0.31%Today’s Change | 40.01 Today|||52-Week Range 63.86 | -11.69% Year-to-Date |
Latest PRGO News | Press Releases
| New Strong Sell Stocks for October 15th Oct 15 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 45.48 |
| Today’s open | 45.70 |
| Day’s range | 45.27 - 45.85 |
| Volume | 431,838 |
| Average volume (3 months) | 792,564 |
| Market cap | $6.2B |
Data as of 4:00pm ET, 10/23/2020
Growth & Valuation
| Earnings growth (last year) | +13.01% |
| Earnings growth (this year) | +0.77% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +2.24% |
| P/E ratio | 26.1 |
| Price/Sales | 1.46 |
| Price/Book | 1.07 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BHCValeant Pharmaceutic... | +0.01 | +0.05% |
| IONSIonis Pharmaceutical... | +0.15 | +0.32% |
| ---- | ||
| RAREUltragenyx Pharmaceu... | +1.16 | +1.26% |
Data as of 4:25pm ET, 10/23/2020
Financials
| Next reporting date | November 4, 2020 |
| EPS forecast (this quarter) | $0.85 |
| Annual revenue (last year) | $4.8B |
| Annual profit (last year) | $146.1M |
| Net profit margin | 3.02% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
